Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot deformities. The company recently ...
BTIG analyst Ryan Zimmerman upgraded Treace Medical (TMCI) to Buy from Neutral with a $16 price target The company has pivoted away from ...